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ABSTRACT Reported associations between air pollution and pulmonary and cardiovascular diseases prompted studies on the
effects of gold nanoparticles (Au NP) on pulmonary surfactant function. Low levels (3.7 mol % Au/lipid, 0.98% wt/wt) markedly
inhibited adsorption of a semisynthetic pulmonary surfactant (dipalmitoyl-phosphatidylcholine (DPPC)/palmitoyl-oleoyl-
phosphatidylglycerol/surfactant protein B (SP-B); 70:30:1 wt %). Au NP also impeded the surfactant’s ability to reduce surface
tension (g) to low levels during ﬁlm compression and to respread during ﬁlm expansion. Transmission electron microscopy
showed that Au NP generated by a seed-growth method were spherical with diameters of ;15 nm. Including palmitoyl-oleoyl-
phosphatidylglycerol appeared to coat the NP with at least one lipid bilayer but did not affect NP shape or size. Similar overall
observations occurred with dimyristoyl phosphatidylglycerol. Dipalmitoyl-phosphatidylglycerol was less effective in NP capping,
although similar sized NP were formed. Including SP-B (1% wt/wt) appears to induce the formation of elongated strands of
interacting threads with the ﬂuid phosphatidylglycerols (PG). Including DPPC resulted in formation of aggregated, less spherical
NP with a larger size distribution. With DPPC, strand formation due to SP-B was not observed. Agarose gel electrophoresis
studies demonstrated that the aggregation induced by SP-B blocked migration of PG-coated NP. Migration was also inﬂuenced
by the ﬂuidity of the PGs. It is concluded that Au NP can interact with and sequester pulmonary surfactant phospholipids and, if
inhaled from the atmosphere, could impede pulmonary surfactant function in the lung.
INTRODUCTION
Pulmonary surfactant is essential for normal lung function
(1–3). Surfactant forms a surface-active ﬁlm composed pri-
marily of phospholipids (PL) that coat the air/water hypo-
phase covering the alveolar tissue surface. By lowering
surface tension (g) to near equilibrium during inspiration,
surfactant minimizes the work of breathing. By reducing g to
low values during expiration, surfactant stabilizes the lung at
low lung volumes and limits the tendency to develop pul-
monary edema. Mammalian surfactants contain ;90% lipid
and ;10% surfactant-speciﬁc proteins SP-A, SP-B, SP-C,
and SP-D. Of these, SP-A and SP-D are large, hydrophilic
oligomeric proteins that function primarily in host defense,
whereas SP-B and SP-C are low molecular weight hydro-
phobic proteins that markedly alter the surface properties of
surfactant PL (4–9).
Phosphatidylcholine (PC) and phosphatidylglycerol (PG)
are major surfactant PLs. PLs are hydrophobic amphipathic
substances that spontaneously form vesicles but adsorb and
spread only slowly at the air-liquid interface. This is par-
ticularly true of gel phase PLs, such as the principal surfactant
molecular species dipalmitoyl-phosphatidylcholine (DPPC)
below its bilayer gel to liquid-crystalline phase transition
temperature of 41C. Both SP-B and SP-C enhance adsorp-
tion and spreading of surfactant lipids at the air-liquid in-
terface. SP-B and SP-C also affect the compressibility of
surfactant PL ﬁlms, thereby permitting such ﬁlms to attain
low g-values near 0 mN/m. Such low surface tensions are
required for the normal breathing process (1–3).
Not surprisingly, factors affecting surfactant impact on
pulmonary function. Surfactant deﬁciency, such as can occur
with premature delivery, can lead to development of the
respiratory distress syndrome (RDS), an important cause of
perinatal morbidity and mortality (10,11). Surfactant dys-
function also contributes to signiﬁcant morbidity and mor-
tality with acute lung injury (ALI) and the acute respiratory
distress syndrome (ARDS) (12,13). ALI and ARDS rise
from a number of causes and with these diseases, surfactant
dysfunction is usually, if not always, a secondary effect.
Although the mechanisms involved are not always clear,
considerable evidence has accumulated indicating that pul-
monary function and cardiovascular function can be dra-
matically affected by air pollution (14–19). It is apparent that
ﬁne (,250 nm) and ultraﬁne (,100 nm) airborne particles
can be conducted to the terminal air spaces. However, little is
known about the effects of air pollutants on pulmonary
surfactant function. Therefore, in this study, we examined
the effects of chemically generated gold nanoparticles (Au
NP), as a model air pollutant, on surfactant function using an
artiﬁcial alveolar model, the captive bubble tensiometer
(CBT). The surfactant used was DPPC/palmitoyl-oleoyl-
phosphatidylglycerol (POPG)/SP-B (70:30:1; wt/wt/wt), a
semisynthetic system that displays many of the basic
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properties of natural pulmonary surfactant (20–27). It was
observed that mixing extremely low numbers of Au NP,
,1% wt/wt, with the surfactant system greatly impeded
surfactant PL adsorption. Furthermore, the NP interfered
with the ability of surfactant ﬁlms to achieve low g-values
during quasistatic or dynamic ﬁlm compression and to
respread to maintain relatively low g-values during surface
area expansion. These observations prompted a further ex-
amination of the interactions between the major surfactant
PL constituents and Au NP. The effect of SP-B, a critical
surfactant apoprotein previously demonstrated to be essential
for normal gaseous exchange, on PL/Au NP interactions was
also investigated. In both cases, highly speciﬁc interactions
were noted between the surfactant constituents. In keeping
with previous studies, it appeared that Au NP become
‘‘capped’’ in the presence of acidic surfactant phospholipids.
This interaction was markedly altered in the presence of SP-
B, which resulted in highly aggregated Au NP. This latter
observation may, in part, explain the highly deleterious
effect of the NP on the ability of surfactant PL to adsorb and
to reduce surface tension to low values, as determined during
surface area expansion/compression cycling.
EXPERIMENTAL
Materials
Standard chemicals were from VWR (Mississauga, Ontario,
Canada), unless noted. Tetrachloroauric acid (HAuCl4),
sodium borohydride (NaBH4), and trisodium citrate were
obtained from Sigma/Aldrich (Oakville, Ontario, Canada).
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-
dimyristoyl-phosphatidylcholine (DMPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt)
(POPG) (16:0-18:1), 1,2-dipalmitoyl-sn-glycero-3-[phospho-
rac-(1-glycerol)] (sodium salt) (DPPG) (di-16:0), and 1,2-
dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium
salt) (DMPG) (di-14:0) were procured from Avanti Polar
Lipids (Birmingham, AL). The pulmonary SP-B was iso-
lated from a clinical surfactant, bovine lipid extract surfactant
(BLES), as described earlier (28). Ultrapure water was used
for all aqueous preparations.
Preparation of lipid-capped gold nanoparticles
The Au NP and lipid-capped Au NP were prepared by the
seed growth (S-G) method. For the seed solution, 20 ml of
0.5 mM HAuCl4 aqueous solution were taken in a screw-
capped glass bottle and dry sodium citrate was added to
make a ﬁnal concentration of 0.5 mM. Then, 0.6 ml of
aqueous 0.1 M NaBH4 solution were added under constant
stirring, giving rise to a ruby red color in the ﬁnal solution,
which acts as the seed solution. The growth solution was
prepared by taking 120 mg of lipid (1 mg/ml) in chloroform
or as otherwise speciﬁed, in a glass screw-capped tube. The
chloroform was evaporated under the ﬂux of pure N2 leaving
a dried lipid ﬁlm around the bottom of the tube. Pure water (5
ml) was added along with two to three small glass beads and
the tube was vortexed for several minutes to completely
disperse the lipid in the aqueous phase. This was followed by
the addition of HAuCl4 so as to make [HAuCl4] ¼ 0.5 mM,
which gave a light yellow color to the solution. Then, 0.5 ml
of the previously prepared seed solution was added, followed
by 0.2 ml of freshly prepared 0.1 M aqueous ascorbic acid
solution. This addition gave an instant deep ruby red color to
the suspension. The suspension was mixed by inverting the
tube several times and kept in the dark without disturbing it
at least for 2 days. Control noncoated blank Au NP particles
were prepared as above, but omitting the PL. The pH of the
NP suspensions was always close to neutral in each case.
Puriﬁcation of each aqueous sample of control and lipid-
capped NP was carried out by repeated washing at least 3–4
times with;10 ml distilled water by centrifugation at 10,000
rpm for 10 min, pouring off the supernatant and redispers-
ing the precipitate in H2O each time to remove soluble
chemicals.
Analytical methods
Captive bubble tensiometry
The surfactant suspensions were made by mixing the con-
stituents (DPPC/POPG; 70:30 with and without 1% SP-B) in
chloroform and drying the resulting solution with a stream of
dry nitrogen to form a thin ﬁlm on the walls of a glass tube.
The dried surfactant ﬁlms were then dispersed within the
following buffer (in mM): 150 NaCl, 2 Tris-HCl, pH 7.4, and
1.5 CaCl2, to give a ﬁnal lipid concentration of 200 mg/ml.
The surface properties of these suspensions were then
studied with and without addition of naked (i.e., nonlipid-
capped) Au NP. Samples were incubated at 37C for at least
1 h before being inserted in the CBT chamber as below.
Surface properties were examined employing a custom-
designed CBT as described previously (24,29). Brieﬂy, after
ﬁlling the chamber and allowing it to equilibrate to 37 6
1C, an air bubble (;8 mm diameter) was sucked into the
suspension at atmospheric pressure. The bubble rose to rest
against a hydrophilic agar plug that apparently eliminates
any detectable loss of surface-active material (i.e., so-called
ﬁlm leakage). Changes in bubble shape were recorded with
a video camera for 1 h or until the PL equilibrium g (geq) of
;23 mN/m was attained. In some cases where geq was not
attained, the duration of the adsorptive phase was prolonged.
After adsorption, the bubble chamber was sealed and the
surface area of the bubble was systematically compressed
and expanded in either quasistatic or dynamic modes (30
cycles/min), as described previously (24,30). Images doc-
umenting alterations in bubble shape were recorded continu-
ously and were subsequently analyzed using custom designed
software (31).
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Quasistatic experiments were conducted by increasing the
pressure in the sample chamber stepwise, such that the rela-
tive bubble area decreased, and waiting 10 s between steps.
We conducted three quasistatic cycles with an intercycle
delay of 1 min to allow reequilibration of the system. With
control surfactant, the bubble progressively ﬂattened, indi-
cating lower g. The minimum g (gmin) was achieved when
the bubble decreased in size with no further reduction in g.
Overcompression was avoided wherever possible. Dynamic
cycles were conducted by setting the bubble volume limits
on the basis of the quasistatic compression-expansion cycles
and then cycling the bubble between these relative bubble
surface areas 620% at 10 cycles/min.
All experiments were performed at least 3 times using
individual freshly prepared samples. Standard deviation of
the mean was obtained from n¼ 3 or more sets of data, using
separate samples. Statistical analysis was done using analysis
of variance techniques and Tukey’s honestly signiﬁcant dif-
ference test for multiple comparisons among the reconsti-
tuted surfactants.
Ultraviolet spectroscopy
Ultraviolet-visible (UV-vis) spectra of the prepared samples
were taken by a UV spectrophotometer (Multiskan Spec-
trum, Thermo Fisher Scientiﬁc, Waltham, MA) in the wave-
length range of 200–900 nm. The formation of Au NP
was monitored in the visible absorption range of 530 nm.
The shape and size of the gold NP were characterized by
transmission electron microscopy (TEM). Samples were pre-
pared by mounting a drop of aqueous NP suspension on a
carbon-coated Cu grid and allowing it to dry in air. Samples
were then observed with the help of a Philips CM10 trans-
mission electron microscope (Eindhoven, The Netherlands)
operating at 100 kV.
Gel electrophoresis
The polarity of the lipid-capped NP samples was determined
by gel electrophoresis using TBE (tris-borate, 90 mM;
ethylene diamine tetraacetic acid (EDTA), 2 mM, pH 8.0)
buffer as a gel running medium. For this purpose, 1% of
aqueous agarose solution was ﬁrst heated to boiling with a
microwave, poured into a gel plate, and allowed to harden.
Then 20 ml of aqueous NP solution was loaded in each gel
well and a direct voltage of 90 V was applied for 10 min to
promote the movement of NP. No staining agent was needed
because the NP solutions in each case were colored (either
pink or purple).
RESULTS
Effect of Au NP on pulmonary surfactant function
Initial studies investigated the potential effects of Au NP
as a model metal air pollutant on pulmonary surfactant. A
chemically deﬁned semisynthetic surfactant composed of
DPPC/POPG/SP-B (70:30:1) was employed because this
system is chemically deﬁned and has been extensively char-
acterized by our group and others (20–27). The effect of Au
NP as an air pollutant was studied by adding blank, naked
(i.e., noncapped) NP to suspensions of DPPC/POPG/SP-B
(70:30:1). The surface activity of these surfactant systems
was then determined with the help of a CBT. Fig. 1 shows
that DPPC/POPG (70:30) suspensions (open circles) at 200
mg/ml initially adsorb relatively rapidly, thereby lowering
g from 70 mN/m (H2O at 37C) to reach g  40 mN/m by
30 min with little further change to 60 min. Inclusion of 1%
SP-B (squares) clearly augmented adsorption such that the
surfactant system reached the equilibrium g (geq) of 23 mN/m
at;15 min. Addition of various amounts of naked Au NP to
DPPC/POPG/SP-B mixtures led to a decrease in adsorption.
At a PL/Au mol ratio of 27 (i.e., [DPPC/POPG]/[Au] ¼ 27),
corresponding to 3.7 mol % or with 0.98% wt/wt Au, the
lowest concentration examined, surfactant adsorption was
drastically impeded so that g decreased only slowly to ;52
mN/m within 60 min (diamonds). The adsorption in the pres-
ence of Au NP was considerably slower and less complete
than in the absence of SP-B.
To maintain normal pulmonary function, surfactant ﬁlms
must achieve low g near zero during expiration (i.e., com-
pression) and maintain g-values near equilibrium during in-
spiration (i.e., surface area expansion). Figs. 2 and 3 show
quasistatic cycles (ﬁrst and third) and dynamic cycles (ﬁrst
and 21st), which are designed to mimic the expansion-
compression cycling of the alveolar surface during breath-
ing. Progressive quasistatic compression (solid circles) of
adsorbed DPPC/POPG/SP-B (70:30:1) ﬁlms (Fig. 2 a) led to
a slow and then more rapid reduction in g until surface
FIGURE 1 Adsorption isotherms of DPPC/POPG (70:30) (circles),
DPPC/POPG/SP-B (70:30:1) (diamonds), and DPPC/POPG/SP-B with
control, noncapped Au NP (3.7 mol % Au/PL) (squares). Isotherms were
obtained by monitoring the adsorption of 200 mg/ml of lipid, lipid-protein,
or lipid-protein-NP mixtures in the captive bubble tensiometer at 37C.
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tensions of ,2 mN/m are attained with a surface area
reduction of ;30%. Film expansion (open squares) resulted
in an immediate and then more gradual increase in g to
values of;30 mN/m at the original bubble size. By the third
quasistatic cycle (Fig. 2 b), g reduction during compression
occurs more directly and surface area reductions of ;15%
are sufﬁcient to attain g-values near zero. This is only
slightly larger than the 12% surface area reductions observed
with DPPC ﬁlms (1). Furthermore, the g-values exhibited
during ﬁlm expansion remain lower than observed at the
same relative areas in the initial cycle. These observations
indicate the ﬁlm has somehow become reﬁned during surface
area cycling.
Adding naked Au NP to the surfactant mixture resulted in
a marked deterioration in surface ﬁlm properties. Fig. 2 c
demonstrates that compression of surfactant ﬁlms in the
presence of Au NP particles (3.7 mol %, 0.98% wt/wt PL)
greatly hampered g reduction during ﬁlm compression
from;45 mN/m. Reducing the surface area by half resulted
in a gmin of;23 mN/m, similar to the geq obtained with the
pure surfactant system. Further compression did not result
in a corresponding reduction in gmin (not shown). Such
overcompression was avoided in the results depicted here.
Film expansion led to gmax values .50 mN/m. By the
third cycle, compressibility was slightly improved but gmin
remained at ;23 mN/m. Surface tension reduction during
ﬁlm expansion was also slightly improved, as indicated by an
expansion plateau near 40 mN/m, but gmax still remained at
;50 mN/m. In other studies, with prolonged adsorption
where ﬁlm compression was initiated at ;40 mN/m, gmin
still remained at ;20 mN/m with cycles 1 and 3.
Similar overall results were obtained with control surfac-
tant during dynamic experiments at 30 cycles/min, which
more closely mimic the normal breathing process (Fig. 3).
Low gmin values of ,2.0 mN/m were achieved during
compression with both dynamic cycles 1 and 21. In each
case, ,20% surface area reduction was required. The gmax
values were ;30 mN/m, showing that surfactant PL re-
sponse was similar to that observed with quasistatic cycle 3.
Hysteresis was minimal, especially with cycle 21. Inclusion
of Au NP (3.7 mol %) resulted in gmin values of;20 mN/m,
similar to those observed with the quasistatic studies. Al-
though some improvement was observed with compression/
expansion cycling, the gmax values were high at;50 mN/m,
even with the 21st cycle. Thus, Au NP markedly impeded
both adsorption and the ability to attain gmin near zero during
either quasistatic or dynamic cycling.
Interaction of surfactant constituents with Au NP
The remarkable and unanticipated efﬁcacy of NP to inhibit
surfactant biophysical activity prompted further investiga-
tion on the interactions between Au NP and surfactant com-
ponents. Initial studies examined the effects of individual
surfactant PL molecular species on UV-vis absorption spec-
tra. The effect of including the dimeric hydrophobic protein
FIGURE 2 Quasistatic compression (d)-expansion (s)
isotherms of DPPC/POPG/SP-B (70:30:1) during the ﬁrst
(a and c) and third (b and d) cycles, in the absence (a and b)
or presence (c and d) of blank Au NP (3.7 mol % PL). The
arrows in panel a indicate surface area expansion (up) or
reduction (down).
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SP-B, previously demonstrated to be essential for normal
gaseous exchange (and therefore, life), with these lipids was
also investigated.
As metal particle sizes decrease to the nanosize range there
is a marked increase in surface plasmon resonance, which
originates from the resonance of collective conduction elec-
trons with incident electromagnetic radiation (32–35), result-
ing in a sharp elevation in absorbance in the visible region
around 520 nm. The shape of the resonance peak is qual-
itatively related to the nature of the NP. Small, uniform NP
with a narrow size distribution give a sharp absorbance,
whereas a wide size distribution or any kind of aggregation
leads to a broader absorbance. Fig. 4 depicts the UV-Vis
absorbance of Au NP prepared with individual PLs (DPPC,
POPG, DMPG, DPPG) in the presence or absence of SP-B.
In each case, the POPG-, DMPG-, and DPPG-capped Au NP
show a sharp plasmon resonance close to 530 nm, whereas
DPPC-capped particles show a much broader absorbance
that extends to longer wavelengths. Inclusion of 1% SP-B
results in an instantaneous change in the ruby red color of the
lipid-capped Au NP suspensions to purple, consistent with a
decrease in the intensity at 520 nm with the appearance of a
much broader peak, usually between 600 and 650 nm. This
broader red-shifted adsorbance could arise from the emission
of collective plasmon resonance caused by the aggregation
of Au NP in the presence of SP-B.
The results in Fig. 4 are supported by TEM micrographs
of lipid-capped Au NP formed in the presence or absence of
SP-B. Fig. 5 shows that naked (a and b) and POPG-capped
(c and d) Au NP have similar shape and size distribu-
tions, demonstrating that this PL does not interfere with NP
growth. Both naked and POPG-capped NP appear predom-
inantly present as single entities that are slightly aggregated.
Most are rounded with diameters of 14.6 6 3.8 (n ¼ 3) and
17.4 6 6.8 nm (n ¼ 3) (Fig. 5, b and d). Closer inspection of
FIGURE 3 Dynamic compression (d)-expansion (s)
isotherms of DPPC/POPG/SP-B during the ﬁrst (a and c)
and 21st (b and d) cycles in the absence (a and b) or pres-
ence (c and d) of blank Au NP (3.7 mol % PL).
FIGURE 4 UV-visible spectra of aqueous lipid- (top to bottom, DPPC,
POPG-, DMPG-, and DPPG-) capped gold nanoparticles in the presence and
absence of surfactant protein B (1% wt/wt; see details in the text).
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the TEM images reveals that with POPG, Au NP can be
enclosed with a thin coat of ;4 nm thickness (Fig. 5 e). A
number of lipid membrane studies (36–40) have reported
the thickness of PL bilayers to be ;4nm. Therefore, this
observation is consistent with NP being covered with at least a
single bilayer.
Fig. 5 f demonstrates the effect of adding SP-B where
POPG-capped Au NP appeared to aggregate to form long
threads or strands in the presence of this hydrophobic peptide.
The strands seemed to be made of physically connected NP
structures. In contrast to the loosely connected strings ob-
served in the absence of SP-B, the strands are several particles
thick in a number of places. In addition, with this sample, in
some cases the particles appear to be in direct contact com-
pared to Fig. 5 b, although this could reﬂect the tendency to
pile up in layers. Somewhat similar TEM images were ob-
served with DMPG, alone (Fig. 6 a) and in the presence of
SP-B (Fig. 6 b). With DPPG, however, the particles appeared
somewhat less regular in size and shape (Fig. 7 a) and addition
of SP-B led to a tendency to aggregate rather than to form the
elongated strands.
When DPPC was used as the capping agent, the shape of
the NP became predominantly aspherical (Fig. 8). POPG,
DMPG, and DPPG are the sodium salts of anionic PLs,
whereas DPPC molecules are zwitterionic in nature. Ionic
surfactant molecules are considered to be better capping
agents than nonionic molecules since the former can provide
both charge and steric stabilization (41–43) more effectively
than the colloidal NP. Apart from this, although addition of
SP-B showed some aggregation among the DPPC-capped
NP (Fig. 8 b), no strands were found. The broad surface
plasmon resonance observed for DPPC-capped NP in the
FIGURE 5 TEM micrographs of (a) blank (noncapped)
Au NP and (b) POPG-capped Au NP prepared by the S-G
procedure. The Au NP size distributions for (c) blank Au
NP and (d) POPG-capped Au NP are depicted. An image
consistent with the presence of a POPG bilayer around a
single nanoparticle is shown in panel e. Strand formation
induced by including 1% wt/wt SP-B with the POPG is
shown in panel f.
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absence or in the presence of SP-B (Fig. 8) is consistent with
the TEM observations.
The polarity of the lipid-capped NP can be examined with
the help of gel electrophoresis (Fig. 9). Both POPG- and
DMPG-capped NP move toward the positively charged
electrode. Neither DPPC-capped nor DPPG-capped particles
moved (data not shown). Interestingly, the addition of SP-B
completely blocked movement of POPG- and DMPG-
capped NP (Fig. 9). These results are consistent with the
binding of the positively charged SP-B to the negatively
charged lipid-capped NP resulting in large, relatively stable
aggregates.
FIGURE 6 TEM micrographs of DMPG-
capped Au NP in the absence (a) and presence
(b) of SP-B (1% wt/wt DMPG). The size
distributions of the NP in the absence of SP-B
are depicted in panel c.
FIGURE 7 TEM micrographs of DPPG-
capped Au NP in the absence (a) and presence
(b) of 1% wt/wt SP-B. Size distribution of
panel a is depicted in panel c.
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DISCUSSION
Ultraﬁne air pollutants and pulmonary function
Epidemiological studies have reported that particulates asso-
ciated with air pollutants contribute signiﬁcantly to pulmo-
nary and cardiovascular disease, resulting in higher levels of
morbidity and mortality (14–18). Ultraﬁne particulates (i.e.,
,100 nm diameter) appear to be most potent (14,44,45).
Studies to date have focused largely on asthma and emphy-
sema. Previously reported investigations on surfactant nor-
mally involved relatively large particles. It should be noted
that the results are highly variable and depend not only on the
substance (i.e., cigarette smoke, diesel oil ash, wood ash,
silica), but also on the nature of the study, even with the same
material (44,46–49). It is apparent from these studies that
secondary effects arising from interactions with lung cells
are often involved in surfactant modiﬁcations and that re-
active oxygen species can contribute.
Effect of Au NP on surfactant function
The potential effects of Au NP as air pollutants on pul-
monary surfactant function was examined by mixing naked
Au NP prepared by the S-G method, as indicated in the
Experimental section, with DPPC/POPG/SP-B (70:30:1) and
assaying PL adsorption and surfactant ﬁlm surface activity
during quasistatic and dynamic compression/expansion
cycling with a CBT. Adding SP-B to DPPC/POPG resulted
in a marked increase in PL absorption rate to the geq of ;23
mN/m. Further addition of Au NP at 3–7 mol % of PL, the
lowest level examined markedly impeded surfactant adsorp-
tion. Adsorption was much slower than with PL in the
absence of SP-B.
Surfactant PL adsorption is critical when an infant is born
and for maintaining surfactant ﬁlm levels to increase lung
compliance and reduce the work of breathing. However, to
maintain normal pulmonary function, surfactant ﬁlms must
achieve g-values near zero during expiration (i.e., compres-
sion) and maintain g-values near equilibrium during inspi-
ration (i.e., surface area expansion) (1,3). In addition to
FIGURE 8 TEM micrographs of DPPC-cap-
ped Au NP in the absence (a) and presence (b)
of 1% wt/wt PL SP-B. Note the presence of
small and nonspherical NP. Size distribution of
panel a is depicted in panel c.
FIGURE 9 Gel electrophoresis showing the displacement of POPG- and
DMPG-capped Au NP toward the positively charged electrode. Note the
absence of any displacement of lipid-capped nanoparticles in the presence of
1% SP-B. No staining agent has been used.
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adsorption, addition of Au NP as low as 3.7 mol %, which
corresponds to 0.98% w/w PL, also inhibited the ability of
surfactant ﬁlms to attain low g-values during either quasi-
static or dynamic compression.
Taken together, the results of these CBT studies demon-
strate that inclusion of small amounts of Au NP dramatically
alters the surface properties of the surfactant system in three
distinct ways. First, Au NP interfere with the adsorption of
PL to form a surface ﬁlm at the geq of ;23 mN/m (Fig. 1).
Second, adding naked NP greatly hampers the ability of the
surfactant system to lower g during ﬁlm compression so that
gmin increased to a value similar to the geq of;23 mN/m for
this system during either quasistatic or dynamic cycling
(Figs. 2 and 3). Such gmin values could hamper optimal
gaseous exchange in vivo (3). Third, the presence of NP
interferes with the respreading of surfactant PL from surface
collapse phases during ﬁlm expansion in either quasistatic or
dynamic cycling modes. Depressed PL respreading leads to a
progressive increase in g during compression/expansion
cycling, at least potentially, leading to enhanced pulmonary
edema (1,30). Thus, the presence of nanoparticles not only
impedes the ability of pulmonary surfactant to adsorb to
equilibrium, a process particularly critical at birth, but also
obstructs the ability of the adsorbed surface ﬁlms to attain
low g-values during compression and to maintain relatively
low g-values during expansion, properties that are crucial for
preventing alveolar collapse.
Interactions between NP and
surfactant constituents
Mammalian pulmonary surfactants contain ;80% PL (wt/
wt), 5–10% neutral lipid (mainly cholesterol), and ;10%
surfactant proteins. Surfactant PL are composed of ;80%
PCs, ;12% PG, with smaller amounts of phosphatidylino-
sitol, phosphatidylethanolamine, lyso-bis-phosphatidic acid,
and sphingomyelin (50). The PC fraction contains 30–50%
DPPC and the PG fraction contains;10% DPPG. The TEM
studies revealed diameters of Au NP grown in the presence
of POPG (17.4 6 3.0 nm, n ¼ 3), DMPG (14.6 6 7.2 nm,
n ¼ 3), or DPPG (17.2 6 5.9 nm, n ¼ 3) were similar
to naked Au NP generated in the absence of lipid. The
following scheme presents a plausible mechanism to explain
Au NP capping. Growing Au NP from the seed solution are
stabilized by negatively charged citrate ions. Under the con-
ditions used, these could be released slowly, possibly ac-
companied by salt formation with sodium ions arising from
the PG salts, as the citrate ions are replaced with negative
charges from phosphate moieties in the acidic PG head-
groups (51). Due to their amphipathic nature, PGs assem-
bling on the particle would gain accompanying PGs, tail to
tail, as directed by H2O-repulsing energies arising from the
hydrophobic effect. Consequently, Au NP would become
covered with PGs, which in the case of POPG appear to form
at least a single bilayer (Fig. 5 e). This conclusion is supported
by cryotransmission electron microscopic studies by Mornet
et al. (52), which demonstrated that silica NP are readily coated
with a bilayer of neutral zwitterionic PCs and slightly nega-
tive PC/phosphatidylserine mixtures. Bilayer-protected Au
NP have also been generated using the cationic detergent
didodecyl dimethylammonium bromide (53) under condi-
tions similar to those used here. The similar size distribution
and uniform shapes of the Au NP grown in the presence and
absence of ﬂuid PGs indicate these PL layers are sufﬁciently
permeable to allow particle growth to be completed during PG
capping.
This appearance contrasts with that of Au NP grown in the
presence of DPPC. Here, the size distribution was greatly
altered, with large numbers of small, spherical NPs mixed
with very large aspherical NPs (Fig. 8). The marked difference
observed between PC and PG is consistent with previous
studies, indicating ionic surfactant molecules are superior in
contributing to both charge and steric stabilization (41–43,54).
It appears that the zwitterionic DPPC inhibits accretion of Au
molecules on some crystal planes, while leaving other crystal
planes at least partially exposed for further growth in an aniso-
tropic manner that generates many nonspherical NP.
It should be noted that in addition to affecting particle size
and shape, zwitterionic DPPC-capped Au NP exhibited a
different overall organization where the PC-capped particles
appeared clumped in several layers. In addition, possibly
because the layering made it more difﬁcult to examine, Au
NP capped with this saturated PC were not clearly separated.
These TEM images were obtained by evaporating aqueous
droplets of Au NP on carbon-coated grids. Thus, it was not
surprising that the NP tended to form single-layered clumps
(Figs. 5, a and b, 6 a, and 7 a), which in some cases appeared
as pearls on a string (e.g., Fig. 6 a). During these TEM
studies, it was noticed that the overall distribution of PL-
capped Au NP was inﬂuenced by including 1% SP-B (wt/
wt). In all cases, in the presence of SP-B the ﬂuid PG-capped
NP formed elongated strand-like structures that were several
layers thick in places. However, this transformation was
considerably less evident with the DPPG-capped particles.
Also, with DPPC-capped NP, particle strand formation could
not be observed. Because the TEM samples are prepared by
drying aqueous dispersions of the samples, the clumping and
string formation observed could arise in part during drying.
However, we were struck by the consistent appearance of
thick Au NP strands, often several particles deep, with all of
the samples containing SP-B and ﬂuid PGs, but not in the
other samples. These strands formed whether the Au NP were
generated in the presence of PG/SP-B or the lipid/protein
complex was added afterwards. These morphological changes
are consistent with the well-recognized ability of SP-B to act
as a ‘‘fusogen’’, as demonstrated by its ability to effectively
destabilize bilayer integrity and morphology and promote lipid
mixing (i.e., stimulate the interactions between lipid moieties
present on the outer leaﬂet of bilayer vesicles) (5,55,56). These
properties contribute to SP-B’s role in the adsorption of sur-
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factant from surface active ﬁlms and the ability of such ﬁlms
to attain very low g-values during compression.
Gel electrophoresis in agarose was also used to investigate
the effect of SP-B on PL-capped Au NP. As anticipated,
POPG- and DMPG-capped Au NP migrated toward the
anode, although the latter NP exhibited considerable streak-
ing. This may be attributed to the considerably higher gel/
liquid crystalline bilayer Tc of the disaturated DMPG (25C)
relative to the unsaturated POPG (1C) (57,58) and suggests
ﬂuidity is critical toward allowing the capped PG/Au com-
plexes to migrate under the electromotive gradient. This pre-
sumably also explains the failure to observe complete capping
of these NP with DPPG and DPPC bilayers. The observation
that including 1% SP-B completely abolished migration of
both POPG- and DMPG-capped Au NP indicates that the
elongated strands shown in Figs. 5 and 6 are stable aggregates.
This is consistent with the red shift observed with UV/vis.
It should be noted that the immobility of SP-B-containing
complexes cannot be attributed to the positive charges on
SP-B. Mature SP-B contains eight positively and one neg-
atively charged amino acid, but calculations show that under
our conditions there are over 1000 negatively charged PG
molecules per SP-B monomer. The aggregation to form long
strands could result in the sequestering of surfactant lipids and
SP-B in the hypophase.
The mechanisms involved in surfactant inhibition are not
well understood. Surfactant inhibition by serum albumin, for
example, is thought to occur through the ability of albumin to
monopolize the surface (1,59). It is thought that the small size
of albumin molecules enables them to adsorb rapidly and
thereby hinder subsequent adsorption of surfactant PL. Sep-
arate studies conducted with a Wilhelmy plate demonstrated
that Au NP are not surface active (data not shown). Thus, to
interfere with surfactant function, Au NP would have to ad-
sorb as coated particles. Studies conducted by others have
demonstrated that laurylamine-coated and carboxylic acid
terminated alkylthiol-derivatized Au NP can form monolayers
(60,61). Furthermore, such monolayers are relatively unstable
and did not reduce g to below 50 mN/m during compression.
However, there is no reason to anticipate more rapid adsorp-
tion of PL/SP-B-coatedAuNP than of PL/SP-Bvesicles alone.
In addition, albumin inhibition requires higher concentrations
of this protein than of the surfactant (59,62,63), but in this
case there is a .25-fold excess of PL molecules over Au
atoms. The PL molecules will be present in large aggregates,
but the Au atoms are assembled into particles. Calculations
show that Au NP of 15-A˚ diameter contain ;100,000 Au
atoms, whereas Au NP of 20-A˚ diameter contain over
200,000 Au atoms. Thus, stochiometric considerations are
complicated. In the absence of any theoretical reason or ex-
perimental evidence for selective adsorption of PL-coated Au
NP and the relatively low concentration of these particles, we
believe it unlikely that Au NP could inhibit pulmonary
surfactant by monopolizing the air-liquid interface. Further-
more, unless g rises above the equilibrium spreading g of;50
mN/m (60), albumin tends to be squeezed out of surfactant
ﬁlms and thus the inhibition overcome during ﬁlm compres-
sion/expansion cycling. Thus, although lipid-capped Au NP
can form monolayers, this inhibition mode is not consistent
with the observed physicochemical surface characteristics.
Another inhibitory mechanism occurs with proteins, such
as ﬁbrinogen and C-reactive protein (CRP), which appear to
inhibit surfactant by binding PL molecules (61–63). The
inability of surfactant samples containing Au NP to reduce
surface tension to below 20 mN/m during compression
resembles the surface characteristics noted with CRP reason-
ably closely. Fibrinogen likely inhibits surfactant by precip-
itating surfactant PL and proteins. CRP is a pentamer of
identical 24 kDa subunits, each of which can bind a single PC.
Although the PC binding is presumably related to the
inhibition of the adsorption of pulmonary surfactant ﬁlms to
attain low g during compression, the manner is still not
understood. This latter inhibition was observed with 50%
CRP (wt/wt), whereas NP inhibition required ,1% Au NP
wt/wt of surfactant. The special properties ofNP arise through
the extremely large increase in a particle’s surface area, which
occurs as its diameter decreases. Consequently, our original
interpretation of the results was that PL and possibly SP-B
were sequestered on the Au NP surfaces and therefore less
available for surface ﬁlm formation. This could be considered
analogous to the binding of PC by CRP. However, calcula-
tions based on the unit volume of Au atoms, the 3.7 mol %
Au/PL, and assuming 70 A˚2 per PL molecule showed that the
model pulmonary surfactant samples contain sufﬁcient PL
to cover particles of 15 nm with bilayers .1300-fold and
particles of 20 nm diameter with bilayers .1700-fold.
The presence of this ‘‘excess’’ PL relative to Au NPmade it
apparent that Au NP possess a highly unusual ability to inhibit
pulmonary surfactant and led us to seek an alternative expla-
nation. The observation that addition of SP-B led to the for-
mation of elongated strands with ﬂuid PGs (Figs. 5 f and 6 b)
provides a potential mechanism for sequestering surfactant
SP-B and PG. This conclusion is supported by gel electropho-
resis (Fig. 9), which shows SP-B induces strong aggregation
of AuNP. In the absence of evidence for any other mechanism,
we consider that the formation of such strands is themost prob-
able basis for surfactant inhibition by low levels of Au NP.
Considerable evidence has accrued demonstrating that
airborne pollutants can access and are retained by the ter-
minal alveolar air spaces (64,65). Should Au NP become
airborne either in the general environment or in the work-
place, one can envision the following circumstance. Pulmo-
nary surfactant adsorption to form a surface ﬁlm normally
occurs through unique vesicular structures known as tubular
myelin. Au NP inhaled into the alveolar space during the
breathing process could impact with such surface ﬁlms,
become wetted, and lined with PL bilayers (Fig. 10). These
bilayers could remove PL from the surface monolayer and
may or may not become enriched with PG due to speciﬁc
interactions. Once in the subphase, coated particles would
864 Bakshi et al.
Biophysical Journal 94(3) 855–868
likely interact with SP-B either from the surface ﬁlm or from
lamellar bodies and could form structures similar to those
observed by TEM. Elongated surfactant strands have been
observed with surfactant ﬁlms treated with residual oil ﬂy
ash particles arising from burning diesel oil (44), but whether
these structures relate to the strands reported here and de-
tected by TEM is not known. Surface balance studies have
demonstrated that dusting DPPC monolayers with tantalum
powder reduced their ability to lower g to low values (66). The
studies described here would suggest that elongated SP-B, PG,
and Au NP-containing strands would not only sequester PL,
impeding PL adsorption, but also inhibit the ability to attain
the low g-values required to stabilize alveoli during expira-
tion. In addition, because respreading is poor, high g-values
.50 mN/m could arise, as observed in Figs. 2 and 3. This
would subject the surface ﬁlm to other inhibitors, such as
serum proteins including albumin, which has been shown to
interfere with surfactant function at high g-values (60). At
present, the fate of Au NP localized to the alveolar space is
not known. The ultraﬁne particles derived from burnt diesel
fuel have pulmonary half-lives in days (45). Au NP particles
in the lung could be removed by lung macrophages, could be
taken into the pulmonary interstitial cells, or could be ab-
sorbed into the blood stream (64,65). However, the likeli-
hood exists that these particles could persist in the alveolar
space for long periods.
None of the previously reported effects on pulmonary sur-
factant function appear to approach the dramatic effects on
biophysical activity noted here. These studies would suggest
that, through their ability to hamper surfactant function, ultra-
ﬁne particles could also contribute to the development of ALI
and ARDS. It must be emphasized that this does not mean that
ultraﬁne particles necessarily act as the direct inducers of the
pulmonary disease. Recent investigations havemade it appar-
ent that ALI or ARDS can arise as a result of a ‘‘two-hit’’
process, where the initial events predispose the lung to clin-
ical expression of ALI (12,13). Hence, individuals subject
to direct primary insult, such as acid aspiration, toxic gas
inhalation, near-drowning, and hyperoxia, or indirect insults,
such as systemic sepsis, massive trauma, multiple blood
transfusions, alcoholism, and pancreatitis, may present with
mild or negligible clinically relevant pulmonary inﬂamma-
FIGURE 10 Potential scheme to explain potential in-
hibitory effects of Au NP on pulmonary surfactant in the
alveolar space (not to scale). (a) A continuous surfactant
ﬁlm (monolayer and underlying multilayer) formed by the
rupture of pulmonary surfactant vesicles at the air-liquid
interface as the hypothetical rate-limiting intermediate
structure between bilayer vesicles and the interfacial
monolayer (see the literature (3,7,67) for further details).
(b) The disrupted interfacial surfactant ﬁlm due to the
entrapping of Au NP (from the air phase as pollutants) by
pulmonary surfactant. (c) The self-aggregation of lipid-
capped Au NP in the presence of SP-B shown in red (see
details in the text).
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tion. Nevertheless, when subject to a secondary event, which
can be a second of the primary events listed above, or to
other insults, such as mechanical ventilation, can result in a
frank overwhelming (as opposed to a mild protective)
primary response leading to ALI and ARDS. As stated
earlier, the surfactant dysfunction usually accompanying
these latter syndromes can act as a progressive factor. Given
these and previous results indicating particulates and in
particular ultraﬁne particles can impact negatively on sur-
factant function, it appears highly possible that ultraﬁne
particles such as Au NP could act as a contributing factor to
ALI and ARDS.
Concluding remarks
The continuing increases in air pollution have generated
serious concern for human health. The respiratory system is
the primary target of air pollutants, to which all human
beings are exposed. This study examined the potential effects
of metal NP, as a model air pollutant, on the surface activity
of a semisynthetic pulmonary surfactant, DPPC/POPG/SP-B
(70:30:1). The presence of Au NP at 3.7 mol %, 0.98 wt%
(Au/PL) dramatically reduced the surface activity of this
system. Both surfactant adsorption to form a surface ﬁlm and
the ability of this ﬁlm to attain low g-values during
compression were compromised. A simple model has been
presented to describe the potential behavior of NP at the air-
liquid interface of the alveoli. These investigations were
extended to examine interactions between Au NP and
individual surfactant components. The results show that
surfactant anionic PL have a strong afﬁnity for Au NP and
can cap Au NP in the form of one or likely more lipid
bilayers, which provides charge and steric stabilization to
colloidal NP. The presence of SP-B, which also interacts
strongly with PG, leads to self-assembly of Au NP into
elongated strand-like structures. This may be related to the
fusogenic properties of this hydrophobic surfactant apopro-
tein. Similar observations resulted whether the Au NP were
synthesized in the presence of PL or naked Au NP were
added to an aqueous suspension of pulmonary surfactant. We
expect a similar type of association between metal NP and
pulmonary surfactants could occur when blank metal NP are
inhaled during the normal breathing process. These results
have possible relevance to the potential ability of ultraﬁne
particulates to promote the development of ALI and ARDS.
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